SIGA Technologies Target of Unusually Large Options Trading (NASDAQ:SIGA)

SIGA Technologies, Inc. (NASDAQ:SIGA) was the recipient of some unusual options trading on Wednesday. Stock traders purchased 1,200 call options on the stock. This represents an increase of approximately 1,438% compared to the typical daily volume of 78 call options.

Institutional Investors Weigh In On SIGA Technologies

A number of large investors have recently modified their holdings of SIGA. DekaBank Deutsche Girozentrale acquired a new stake in SIGA Technologies in the second quarter valued at about $40,000. Bayesian Capital Management LP bought a new stake in shares of SIGA Technologies during the 1st quarter valued at approximately $97,000. Lazard Asset Management LLC acquired a new position in SIGA Technologies during the 1st quarter worth approximately $105,000. EntryPoint Capital LLC bought a new position in SIGA Technologies in the 1st quarter valued at approximately $111,000. Finally, AQR Capital Management LLC acquired a new stake in SIGA Technologies in the second quarter valued at approximately $99,000. Institutional investors and hedge funds own 55.40% of the company’s stock.

SIGA Technologies Stock Performance

Shares of SIGA opened at $6.92 on Thursday. The firm has a market cap of $493.88 million, a P/E ratio of 6.29 and a beta of 0.91. SIGA Technologies has a 52 week low of $4.26 and a 52 week high of $12.83. The firm’s 50-day simple moving average is $8.68 and its 200 day simple moving average is $8.40.

SIGA Technologies (NASDAQ:SIGA) last released its quarterly earnings results on Thursday, August 1st. The company reported $0.03 earnings per share for the quarter. SIGA Technologies had a return on equity of 51.40% and a net margin of 48.55%. The business had revenue of $21.81 million during the quarter. During the same period in the previous year, the business posted ($0.04) earnings per share. As a group, equities analysts forecast that SIGA Technologies will post 1.01 earnings per share for the current year.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.